Price
No data yet.
Social Signal Score
Revenue
$5.83M-21.81%Company Profile
- CEO
- Peter G. Eames
- Sector
- Technology
- Industry
- Semiconductors
- Employees
- 41
- Beta
- 1.29
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 161.84
Financials
Revenue
$5.83M-21.8%Net Income
$3.17M-8.9%EBITDA
$3.21M-38.6%Free Cash Flow
$5.80M+9.5%EPS (diluted)
$0.65-9.7%Shares Outstanding (diluted)
4.85M+0.2%Operating Expenses
$889.7KCash & Debt
$23.65MReturn of Capital
$4.84MRevenue by Segment (annual)
$26.99MDividend per Share
$1.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $26.33M | $15.20M | $3.14 |
| 2025 | $25.87M | $15.06M | $3.12 |
| 2024 | $29.80M | $17.12M | $3.54 |
| 2023 | $38.25M | $22.69M | $4.70 |
| 2022 | $26.99M | $14.51M | $3.00 |
| 2021 | $21.37M | $11.69M | $2.42 |
| 2020 | $25.41M | $14.53M | $3.00 |
| 2019 | $26.47M | $14.51M | $3.00 |
| 2018 | $29.86M | $13.91M | $2.87 |
| 2017 | $28.33M | $12.95M | $2.68 |
| 2016 | $27.72M | $12.29M | $2.53 |
| 2015 | $30.58M | $14.37M | $2.96 |
| 2014 | $25.93M | $11.14M | $2.30 |
| 2013 | $27.03M | $11.83M | $2.44 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from NVEC's reported EPS growth of 2.0% a year over 13 years.
- EPS in 5 years
- $3.47
- Implied price
- $72.85
- Return from $103.07
- -6.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $36.22 — -64.9% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 15 | 18 | 21 | 24 | 27 |
|---|---|---|---|---|---|
| -8.0% | -21.3% | -18.4% | -15.9% | -13.6% | -11.5% |
| -3.0% | -17.1% | -14.0% | -11.3% | -8.9% | -6.7% |
| 2.0% | -12.8% | -9.5% | -6.7% | -4.2% | -1.9% |
| 7.0% | -8.5% | -5.1% | -2.1% | 0.5% | 2.9% |
| 12.0% | -4.2% | -0.7% | 2.4% | 5.2% | 7.7% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
150+200.00%Social Signal Score
Mentions (4)
- Newsfool.com·6h ago·Positive
NVE: 3 Key Takeaways for Long-Term Investors First-half revenue reached $16.9 million, up 36% year over year. Second quarter distributor sales increased 67% year over year.
View source ↗ - Newsmarketbeat.com·9h ago·Negative
NVE Q2 Earnings Call Highlights NVE NASDAQ: NVEC reported second-quarter fiscal 2027 revenue that declined 8% from a year earlier, as lower product sales offset growth in contract research and development revenue. The company said the product-sales decline reflected a short-term inventory adjustment by a large medical-device customer and a sharp drop in defense-related product sales.
View source ↗ - Newsseekingalpha.com·9d ago·Positive
NVE Corporation: Medical-Sensor Innovation Supports A Long-Term Buy NVE Corporation (NVEC) is rated a long-term Buy due to its proprietary spintronics technology, expanding medical-device market presence, and robust profitability. NVEC's ultraminiature magnetic sensors target implantable medical devices, leveraging strong relationships with manufacturers like Abbott Laboratories and recent manufacturing expansions. FY2026 net profit margin reached 58%, with Q1 FY2027 revenue and net income up 81…
View source ↗ - Newsgurufocus.com·34d ago·Neutral
Is NVE Corp (NVEC) Overvalued After 3.1% Rally? GF Value Says Overvalued On September 17, 2026, NVE Corp (NVEC) shares rose 3.1%, bringing the current share price to $100.53. This price remains within a 52-week range of $57.21 to $13
View source ↗
Earnings
Wed, Oct 21(date passed)
Estimates and results for NVEC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by NVEC officers and directors.
- Bought
- $34k
- Sold
- $7.7m
4 trades
21 trades
- Baker Daniel Asold
- Baker Daniel Asold
- Baker Daniel Asold
- Baker Daniel Asold
- Baker Daniel Asold
- Baker Daniel Asold
- Baker Daniel Asold
- Baker Daniel Asold
75 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in NVEC.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.